ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
85.82 EUR
-0.74 (-0.85%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- ABL had positive earnings in the past year.
- In the past year ABL had a positive cash flow from operations.
- ABL had positive earnings in each of the past 5 years.
- Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
- ABL's Return On Assets of 7.52% is amongst the best of the industry. ABL outperforms 85.71% of its industry peers.
- ABL has a Return On Equity of 12.51%. This is in the better half of the industry: ABL outperforms 79.37% of its industry peers.
- With a decent Return On Invested Capital value of 9.17%, ABL is doing good in the industry, outperforming 77.78% of the companies in the same industry.
- ABL had an Average Return On Invested Capital over the past 3 years of 8.63%. This is in line with the industry average of 10.15%.
- The 3 year average ROIC (8.63%) for ABL is below the current ROIC(9.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- With an excellent Profit Margin value of 14.72%, ABL belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- ABL's Operating Margin of 18.85% is fine compared to the rest of the industry. ABL outperforms 79.37% of its industry peers.
- ABL's Operating Margin has improved in the last couple of years.
- ABL has a Gross Margin (56.68%) which is in line with its industry peers.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- ABL has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ABL has less shares outstanding
- The debt/assets ratio for ABL has been reduced compared to a year ago.
2.2 Solvency
- ABL has an Altman-Z score of 4.84. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- ABL has a better Altman-Z score (4.84) than 79.37% of its industry peers.
- The Debt to FCF ratio of ABL is 1.75, which is an excellent value as it means it would take ABL, only 1.75 years of fcf income to pay off all of its debts.
- ABL's Debt to FCF ratio of 1.75 is amongst the best of the industry. ABL outperforms 82.54% of its industry peers.
- ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a better Debt to Equity ratio (0.19) than 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.84 |
ROIC/WACC1.08
WACC8.46%
2.3 Liquidity
- ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Current ratio (1.58) which is comparable to the rest of the industry.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.18, ABL perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
- ABL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
- Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 19.64, which indicates a rather expensive current valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
- ABL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 17.75, which indicates a rather expensive current valuation of ABL.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (38.16), we can say ABL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.64 | ||
| Fwd PE | 17.75 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA is on the same level as the industry average.
- Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 65.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.78 | ||
| EV/EBITDA | 15.77 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.83
PEG (5Y)2.76
EPS Next 2Y10.46%
EPS Next 3Y10.33%
5. ABL.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.45%, ABL has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.23, ABL pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, ABL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
- ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (4/15/2026, 5:23:19 PM)
85.82
-0.74 (-0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.92%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap149.13B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80.57
Price Target115.79 (34.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
Yearly Dividend2.03
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)1.34%
PT rev (3m)-7.03%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.64 | ||
| Fwd PE | 17.75 | ||
| P/S | 3.97 | ||
| P/FCF | 23.78 | ||
| P/OCF | 18.38 | ||
| P/B | 3.37 | ||
| P/tB | 7.79 | ||
| EV/EBITDA | 15.77 |
EPS(TTM)4.37
EY5.09%
EPS(NY)4.84
Fwd EY5.63%
FCF(TTM)3.61
FCFY4.2%
OCF(TTM)4.67
OCFY5.44%
SpS21.63
BVpS25.44
TBVpS11.01
PEG (NY)1.83
PEG (5Y)2.76
Graham Number50.0127 (-41.72%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.84 |
F-Score6
WACC8.46%
ROIC/WACC1.08
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.